Andrew Freywald obtained his Ph.D. in Molecular and Cell Biology at the Weizmann Institute of Science, Israel, and completed his Post-Doctorate training in Molecular Immunology and Cancer research at the Hospital for Sick Children, Toronto, ON, Canada. He is a Professor of Pathology and Laboratory Medicine at the College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada. His research interests include cancer cell biology and tumor biology. He also serves as a scientific advisor for the biotech industry. The work of his research team at the College of Medicine, University of Saskatchewan focuses on investigating and targeting molecular mechanisms that determine tumor aggressiveness, and treatment resistance.